Vaccines with a shot of diplomacy: An analysis of the dynamics of power play between India and China

Zyna Dhillon
{"title":"Vaccines with a shot of diplomacy: An analysis of the dynamics of power play between India and China","authors":"Zyna Dhillon","doi":"10.18231/j.jmra.2023.037","DOIUrl":null,"url":null,"abstract":"This paper aims to portray the strategic usage of vaccine diplomacy by India and China in their efforts for regional and global supremacy.The paper begins with an analysis of power and its types as well as the ways in which it manifests itself in the real world. This is followed by an evaluation of vaccine diplomacy as a soft power and what distinguishes it from other forms of soft power. The paper then segues into a comparative analysis on India and China, with comparisons being made across the following metrics: outreach and quantum of vaccines donated, the conditionality of vaccines, diplomatic incentives and limitations faced in donating vaccines.There is no clear winner in the battle. China trumps over India in terms of outreach but India’s outreach donates vaccines while China sells them. The winner might not be clear but the path that India takes now may determine its future. 1. India must inoculate its domestic population. 2. India must revamp its vaccination program with assistance from its Quad allies. 3. India must begin locally albeit with an aim to go global. 4. India should either drastically subsidize all its vaccines or increase the proportion of vaccines donated for free vis a vis those sold commercially. 5. India must attempt to make inroads in countries where the efficacy of China’s vaccines came under question. 6. India must try to take pre-emptive action to begin research on diseases predicted to rise with the insurgence of climate change. As long as a pathogen exists, some one or the other will hold a monopoly on its vaccine and vaccines will continue to be served with a shot of diplomacy.","PeriodicalId":394459,"journal":{"name":"Journal of Management Research and Analysis","volume":"43 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Management Research and Analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.jmra.2023.037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This paper aims to portray the strategic usage of vaccine diplomacy by India and China in their efforts for regional and global supremacy.The paper begins with an analysis of power and its types as well as the ways in which it manifests itself in the real world. This is followed by an evaluation of vaccine diplomacy as a soft power and what distinguishes it from other forms of soft power. The paper then segues into a comparative analysis on India and China, with comparisons being made across the following metrics: outreach and quantum of vaccines donated, the conditionality of vaccines, diplomatic incentives and limitations faced in donating vaccines.There is no clear winner in the battle. China trumps over India in terms of outreach but India’s outreach donates vaccines while China sells them. The winner might not be clear but the path that India takes now may determine its future. 1. India must inoculate its domestic population. 2. India must revamp its vaccination program with assistance from its Quad allies. 3. India must begin locally albeit with an aim to go global. 4. India should either drastically subsidize all its vaccines or increase the proportion of vaccines donated for free vis a vis those sold commercially. 5. India must attempt to make inroads in countries where the efficacy of China’s vaccines came under question. 6. India must try to take pre-emptive action to begin research on diseases predicted to rise with the insurgence of climate change. As long as a pathogen exists, some one or the other will hold a monopoly on its vaccine and vaccines will continue to be served with a shot of diplomacy.
一针外交疫苗:印度与中国权力博弈动态分析
本文首先分析了权力及其类型,以及权力在现实世界中的表现形式。论文首先分析了权力及其类型,以及权力在现实世界中的表现方式,然后评估了作为软权力的疫苗外交,以及疫苗外交与其他软权力形式的区别。随后,本文对印度和中国进行了比较分析,并从以下几个方面进行了比较:捐赠疫苗的范围和数量、疫苗的条件性、外交激励措施以及捐赠疫苗时面临的限制。中国在外联方面胜过印度,但印度的外联活动是捐赠疫苗,而中国则是出售疫苗。胜负可能并不明显,但印度现在所走的道路可能会决定其未来。1.印度必须为国内人口接种疫苗。2.2. 印度必须在四方盟国的协助下重整疫苗接种计划。3.印度必须从本地开始,但目标是走向全球。4.印度应大幅补贴其所有疫苗,或增加免费捐赠疫苗与商业销售疫苗的比例。5.印度必须尝试在中国疫苗疗效受到质疑的国家取得进展。6.6. 印度必须尝试采取先发制人的行动,开始研究预计会随着气候变化而增加的疾病。只要病原体存在,就会有一方或另一方对其疫苗进行垄断,疫苗将继续通过外交手段提供。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信